Company Data

Mirum Pharmaceuticals Inc.

Ticker
MIRM
Current Price
$52.45 -1.34%
Market Cap
$2.5B
Price Target
Refer to Report
Volume
938.7K
52wk Range
$23.14 - $53.755
Advanced Market Data

Overview

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy